This is a Validated Antibody Database (VAD) review about rat Axl, based on 6 published articles (read how Labome selects the articles), using Axl antibody in all methods. It is aimed to help Labome visitors find the most suited Axl antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Axl synonym: tyrosine-protein kinase receptor UFO

Cell Signaling Technology
rabbit monoclonal (D12B2)
  • western blot; mouse; 1:1000; loading ...; fig 4e
In order to explore the role of Axl in promoting a suppressive myeloid microenvironment in response to ionizing radiation therapy in combination with checkpoint immunotherapy, Cell Signaling Technology Axl antibody (Cell Signaling, 5724) was used in western blot on mouse samples at 1:1000 (fig 4e). Nat Commun (2016) ncbi
rabbit monoclonal (D12B2)
  • western blot; mouse; loading ...; fig 4d
In order to engineer and characterize a second-generation, high-affinity AXL decoy receptor, Cell Signaling Technology Axl antibody (CST, 5724) was used in western blot on mouse samples (fig 4d). J Clin Invest (2017) ncbi
rabbit monoclonal (D12B2)
  • western blot; human; fig 2a, 2b, 2c
Cell Signaling Technology Axl antibody (Cell Signaling, 5724) was used in western blot on human samples (fig 2a, 2b, 2c). Oncotarget (2016) ncbi
rabbit monoclonal (D12B2)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology Axl antibody (cell signalling, 5724) was used in western blot on human samples (fig 4c). Oncotarget (2016) ncbi
rabbit monoclonal (D12B2)
  • western blot; human; fig 3
Cell Signaling Technology Axl antibody (Cell Signaling, 5724) was used in western blot on human samples (fig 3). Int J Cancer (2016) ncbi
rabbit monoclonal (D12B2)
  • western blot; human; fig 6
Cell Signaling Technology Axl antibody (Cell Signaling Technology, 5724) was used in western blot on human samples (fig 6). Oncogene (2016) ncbi
Articles Reviewed
  1. Aguilera T, Rafat M, Castellini L, Shehade H, Kariolis M, Hui A, et al. Reprogramming the immunological microenvironment through radiation and targeting Axl. Nat Commun. 2016;7:13898 pubmed publisher
  2. Kariolis M, Miao Y, Diep A, Nash S, Olcina M, Jiang D, et al. Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies. J Clin Invest. 2017;127:183-198 pubmed publisher
  3. Park J, Lee C, Kim H, Kim D, Son J, Ko E, et al. Suppression of the metastatic spread of breast cancer by DN10764 (AZD7762)-mediated inhibition of AXL signaling. Oncotarget. 2016;7:83308-83318 pubmed publisher
  4. Hsieh M, Yang P, Wong L, Lee J. The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma. Oncotarget. 2016;7:36956-36970 pubmed publisher
  5. van der Mijn J, Broxterman H, Knol J, Piersma S, de Haas R, Dekker H, et al. Sunitinib activates Axl signaling in renal cell cancer. Int J Cancer. 2016;138:3002-10 pubmed publisher
  6. Debruyne D, Bhatnagar N, Sharma B, Luther W, Moore N, Cheung N, et al. ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT. Oncogene. 2016;35:3681-91 pubmed publisher